Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000842023-12-000020

Options or other derivatives

  • VP Hematology Operations acquired 1,097 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

VERONNEAU MARCEL · VP Hematology Operations

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2012-07-27 Grant or award : show line 1 in the form Stock Option +1,097 $74.05 2019-07-26 1,097 1,097 D
Loading xslF345X03/primary_doc.xml…